1,600
Participants
Start Date
May 1, 2019
Primary Completion Date
April 30, 2020
Study Completion Date
April 30, 2020
Patient portal message
Direct-to-patient message via the electronic patient portal (MyHealth) with HCV antibody lab order directed to their preferred laboratory
Stanford University, Palo Alto
Collaborators (1)
Gilead Sciences
INDUSTRY
Stanford University
OTHER